Strides Pharma Science's Stock Hits 52-Week High, Outperforms Sector with Impressive Growth

Strides Pharma Science, a midcap pharmaceutical company, has recently reached a new milestone as its stock price touched a 52-week high on August 29, 2024. This comes as no surprise as the company has been consistently performing well in the market. According to MarketsMOJO, a leading stock analysis platform, Strides Pharma Science's stock is currently rated as 'Hold'. The company's stock has also been a part of Momentumnow Stocks on MarketsMOJO since April 3, 2024. On August 29, the stock hit a new 52-week high of Rs.1348.8, outperforming the sector by 0.89%. The stock also saw an intraday high of Rs.1348.8, showing a 2.96% increase. Additionally, Strides Pharma is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the market. In the past year, Strides Pharma Science has shown an impressive growth of 201.73%, while the Sensex has only grown by 26.03%. This showcases the company's strong performance and potential for future growth. As a midcap company in the pharmaceutical industry, Strides Pharma Science has proven to be a strong player in the market. With its consistent performance and positive outlook, the company is definitely one to watch out for in the coming years.